Senior Director, Supply Chain Management
Ultragenyx Pharmaceutical
Summary
Reporting to the Executive Director, Supply Chain Management, Ultragenyx is seeking a highly motivated Senior Director of Supply Chain Management (SCM) with expertise in end-to-end pharmaceutical program supply chain management for gene therapy. In this position you will be responsible for strategy, development, and oversight of demand and supply for gene therapy programs for all life cycle stages. You will partner with Commercial, Clinical, Manufacturing, Packaging and Labeling, Regulatory, Quality and Program Management to ensure supply across a global network.
Job description
Position Summary
Reporting to the Executive Director, Supply Chain Management, Ultragenyx is seeking a highly motivated Senior Director of Supply Chain Management (SCM) with expertise in end-to-end pharmaceutical program supply chain management for gene therapy. In this position you will be responsible for strategy, development, and oversight of demand and supply for gene therapy programs for all life cycle stages. You will partner with Commercial, Clinical, Manufacturing, Packaging and Labeling, Regulatory, Quality and Program Management to ensure supply across a global network.
Responsibilities
- Accountable for end-to-end gene therapy supply in partnership with the Program Team Leads and Global Commercial Leads.
- Responsibilities include supply chain network strategy development and implementation, multi-stage demand and supply oversight, and on time in full supply execution.
- Develop strategies to deliver quality supply throughout product life cycle in collaboration with Commercial, Clinical, Manufacturing, Packaging, Quality, Regulatory, and Project Management.
- Proactively directs supply life cycle changes, ensuring resource requirements and risks are clearly identified within the Ultragenyx Decision Making Framework.
- Key stakeholder for both internal and external gene therapy manufacturing.
- Consulted in contract development and execution for contract organizations.
- Liaise with Contract Organization (CO) business owners to ensure schedules meet product objectives.
- Represent end-to-end gene therapy supply in Sales / Demand & Operations Planning (S/D&OP) process.
- Ensure S/D&OP plans align with company and product strategy and milestones.
- Provide connection between D/S&OP and CMC sub-team.
- Single point of contact for Supply Chain Management to CMC sub-team lead, maintain strong communication between SCM and the CMC team.
- Responsible for gene therapy Supply Chain compliance with processes and documentation to enable GxP product supply, including completion of Clinical Trial Master Files and adherence to finance requirements.
- Accountable for product master data in supply chain systems, such as Oracle and Kinaxis.
- Manage gene therapy SCM budget; partner with CMC sub-team lead and Finance to drive financially responsible supply plans, e.g., COGS reduction, limit tax and tariff exposure.
- Accountable and responsible for gene therapy inventory management throughout network, including strategy, storage, reconciliation and destruction.
Requirements
- Bachelor's degree in Biotechnology, Supply Chain, Engineering or related STEM discipline and MBA or similar Master's degree.
- 10 – 15 years of supply chain experience
- Minimum of 8 years of experience in biotech / pharmaceutical industry; 3 years in gene therapy
- Experience with Kinaxis, SmartSheet, PowerBI and Oracle or similar systems
- Proficient in quality event documentation practices and Veeva QMS
- Working knowledge of cGXP's and pharmaceutical industry procedures and regulations, including import and export requirements
- Experience leading cross functional teams, e.g., CMC teams, product launch teams
- Independent, self-motivated individual with the ability to manage change through influence
- Strong communication and interpersonal skills. Ability to solicit input, obtain stakeholder buy-in and build cross-functional consensus
- Demonstrated success with change management, including project management tools
- Travel: up to 25%
- Demonstrated experience with Lean / Six sigma / Continuous improvement is highly desirable.
Work Model: Flex: This role will typically require onsite work 2-3 days each week, or more depending on business needs.
Requirements
- Bachelor's degree in Biotechnology, Supply Chain, Engineering or related STEM discipline
- MBA or similar Master's degree
- 10 – 15 years of supply chain experience
- Minimum of 8 years of experience in biotech / pharmaceutical industry
- 3 years in gene therapy
- Experience with Kinaxis, SmartSheet, PowerBI and Oracle or similar systems
- Proficient in quality event documentation practices and Veeva QMS
- Working knowledge of cGXP's and pharmaceutical industry procedures and regulations, including import and export requirements
- Experience leading cross functional teams, e.g., CMC teams, product launch teams
- Independent, self-motivated individual with the ability to manage change through influence
- Strong communication and interpersonal skills
- Ability to solicit input, obtain stakeholder buy-in and build cross-functional consensus
- Demonstrated success with change management, including project management tools
- Travel: up to 25%
- Demonstrated experience with Lean / Six sigma / Continuous improvement is highly desirable
Benefits
- Generous vacation time
- Public holidays
- Volunteer days
- Long term incentive plan
- Employee stock purchase plan
- Employee wellbeing benefits
- Fitness reimbursement
- Tuition sponsoring
- Professional development plans
Company overview
Ultragenyx Pharmaceutical Inc. is a pioneering biopharmaceutical company dedicated to developing and commercializing novel therapies for serious rare and ultra-rare genetic diseases. Founded in 2010 by Dr. Emil D. Kakkis, the company is headquartered in Novato, California and operates globally with a presence in North America, Europe, Asia, and Latin America. Ultragenyx has built a diverse portfolio of approved medicines including Crysvita® for X-linked hypophosphatemia, Mepsevii® for mucopolysaccharidosis type VII, Dojolvi® for long-chain fatty acid oxidation disorders, and Evkeeza® for homozygous familial hypercholesterolemia. The company employs multiple therapeutic modalities including biologics, small molecules, gene therapies, and antisense oligonucleotides to address diseases with high unmet medical needs. With over 1,000 employees and a robust clinical pipeline, Ultragenyx maintains one of the most extensive rare disease development programs in the industry, focusing on metabolic disorders, bone diseases, enzyme deficiencies, and neurological conditions. The company is publicly traded on NASDAQ under the symbol RARE and continues to advance its mission of delivering transformative treatments to patients with limited or no therapeutic options.